Sternal Closure Systems Market Size & Growth Forecast 2027–2036, By Segments (Procedure, Material Type, Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Sternal Closure Systems Market size was valued at USD 3.1 billion in 2026 and is anticipated to grow at a 5.13% CAGR from 2027 to 2036, surpassing USD 5.11 billion by 2036. The industry revenue for 2027 is estimated at USD 3.23 billion.
Get more details on this report
Request Free Sample ReportSternal Closure Systems Market Intelligence Snapshot
Regional Market Dynamics
- North America captured 36.23% of the market in 2026, supported by high cardiac procedure volumes, advanced hospital infrastructure, and routine use of sophisticated sternal closure technologies.
- Asia Pacific is projected to grow at a 6.22% CAGR as surgical volumes increase, hospital capacity expands, and more healthcare providers adopt advanced closure systems for cardiovascular procedures.
Segment Momentum
- Median Sternotomy held a 53.6% market share in 2026 due to its routine use in open-heart surgeries, where dependable sternal closure and post-operative stability remain essential clinical priorities.
- Bilateral Thoracosternotomy is expanding as specialized surgeries increasingly require broader thoracic access, creating stronger demand for closure systems designed to support more complex chest wall procedures.
Market Expansion Drivers
- Rising geriatric population increasing open-heart surgeries requiring sternotomy closure systems.
- Growing volume of cardiothoracic and CABG procedures driving sternal closure demand.
- Shift toward minimally invasive sternotomy and advanced biocompatible closure materials adoption in hospitals.
Leading Market Participants
- Top players in the sternal closure systems market include Johnson & Johnson (United States), Zimmer Biomet Holdings, Inc. (United States), B. Braun SE (Germany), KLS Martin Group (Germany), Orthofix Medical Inc. (United States), Acumed LLC (United States), Kinamed Incorporated (United States), ABLE Medical Devices (United States), Abyrx, Inc. (United States), IDEAR S.r.l. (Italy).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 3.1 billion
- 2027 Estimated Market Size: USD 3.23 billion.
- Projected Market Size: USD 5.11 billion by 2036
- Growth Forecast: 5.13% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Median Sternotomy (Procedure) | Titanium (Material Type) | Closure Devices (Type)
- Emerging Opportunity Segment: Bilateral Thoracosternotomy (Procedure) | Titanium (Material Type) | Closure Devices (Type)
Market Growth Drivers and Industry Trends
Rising geriatric population increasing open-heart surgeries requiring sternotomy closure systems
An expanding geriatric population is contributing to the sternal closure systems market as older patients experience greater demand for complex cardiovascular interventions, including open-heart surgeries requiring sternotomy closure. Hospitals therefore require dependable closure solutions capable of supporting postoperative stabilization, with procurement priorities increasingly linked to the needs of higher-risk surgical populations undergoing cardiac procedures.
Growing volume of cardiothoracic and CABG procedures driving sternal closure demand
The growing volume of cardiothoracic and CABG procedures directly supports the sternal closure systems market because these interventions frequently require secure closure following sternotomy. Increasing procedural activity expands hospital consumption of closure systems and reinforces the need for products that facilitate reliable sternal approximation during postoperative recovery.
Shift toward minimally invasive sternotomy and advanced biocompatible closure materials adoption in hospitals
The sternal closure systems market is being influenced by hospital adoption of minimally invasive sternotomy approaches and advanced biocompatible closure materials, as surgical teams seek solutions compatible with evolving procedural techniques and postoperative requirements. Improvements in material characteristics can support tissue compatibility and closure performance, while newer approaches encourage hospitals to update procurement portfolios around contemporary cardiac surgery practices.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising geriatric population increasing open-heart surgeries requiring sternotomy closure systems | 2.10% | Moderate | North America, Europe, Asia Pacific | High | Near Term |
| Growing volume of cardiothoracic and CABG procedures driving sternal closure demand | 1.90% | Moderate | North America, Asia Pacific | High | Near Term |
| Shift toward minimally invasive sternotomy and advanced biocompatible closure materials adoption in hospitals | 1.60% | High | North America, Europe, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the sternal closure systems market at 36.23% in 2026, driven by advanced cardiovascular surgical infrastructure, high access to specialized cardiac care, and established adoption of sophisticated surgical closure technologies. The region's substantial demand for procedures requiring secure sternal stabilization supports the use of reliable closure systems designed to promote healing and reduce postoperative complications. Increasing preference for improved surgical outcomes, technological advancement in closure techniques, and strong integration of specialized cardiac services are reinforcing regional demand. Well-developed hospital systems and continued investment in surgical innovation further contribute to North America's market leadership.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing regional market, benefiting from expanding cardiac care infrastructure, increasing access to surgical services, and a growing need for effective postoperative management. Rising healthcare expenditure and modernization of hospitals are enabling broader adoption of advanced sternal closure technologies, while improvements in cardiac surgery capabilities are expanding the addressable patient base. Increasing clinician awareness of surgical closure options and greater investment in specialized healthcare facilities are also supporting market penetration. The region's growing focus on improving surgical quality and patient recovery is expected to sustain demand for advanced closure systems.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Surgical IntegrationGermany prioritizes sternal closure systems that improve surgical precision and long-term sternum stability following cardiac interventions. Demand is centered on clinically validated fixation devices that align with the country's preference for high-performance surgical technologies.
France 🇫🇷
Outcome-Oriented ProcurementFrance places strong emphasis on sternal closure systems that demonstrate improved patient outcomes and lower complication rates. Hospitals increasingly favor technologies that can support efficient recovery and optimize resource utilization in cardiac surgery departments.
Italy 🇮🇹
Specialized Cardiac ApplicationsItaly's sternal closure systems market is supported by demand from specialized cardiac centers performing complex surgical procedures. Providers are adopting advanced fixation methods that improve sternum stability and address the needs of high-risk patient populations.
Japan 🇯🇵
Elderly Cardiac Care FocusJapan's aging population is sustaining demand for sternal closure systems used in cardiac procedures among older patients with higher complication risks. Healthcare providers are seeking closure solutions that support healing and reduce the likelihood of reintervention.
South Korea 🇰🇷
Minimally Invasive SupportSouth Korea is expanding the use of advanced sternal closure systems alongside growing adoption of sophisticated cardiac surgery techniques. Market interest is increasing in fixation systems that enhance procedural efficiency and postoperative patient management.
United States 🇺🇸
Advanced Closure AdoptionThe U.S. sternal closure systems market is emphasizing rigid fixation technologies and enhanced closure solutions for complex cardiac procedures. Hospitals are increasingly evaluating products that reduce postoperative complications and support faster recovery pathways in cardiothoracic surgery.
Segment Leadership and Growth Trends
Sternal Closure Systems Market Share (%), by Procedure, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProcedure Segment Analysis: Median Sternotomy (Largest Segment) vs Bilateral Thoracosternotomy (Fastest-Growing Segment)
The median sternotomy segment dominated the sternal closure systems market with a 53.6% share in 2026, reflecting its established role in surgical procedures that require broad access to the thoracic cavity. The procedure provides surgeons with extensive exposure to the heart and surrounding structures, supporting its continued use in complex cardiac and thoracic interventions. Its established surgical workflow and the corresponding need for reliable sternal stabilization further sustain demand for closure systems designed to restore chest wall integrity following the procedure.
Bilateral thoracosternotomy is gaining traction as surgical techniques evolve and clinicians seek approaches that provide effective access to thoracic structures in appropriate procedures. The growing emphasis on procedure-specific surgical strategies and improved postoperative management is encouraging interest in closure technologies compatible with alternative thoracic access methods. Continued advances in surgical practice and the need for dependable stabilization following thoracic procedures are supporting the segment's faster development.
Material Type Segment Analysis: Titanium (Largest & Fastest-Growing Segment)
Titanium held the largest share of the sternal closure systems market at 46.33% in 2026 and is also the fastest-growing material type, supported by its combination of strength, durability, and biocompatibility. Titanium-based closure systems are well suited to applications requiring secure stabilization of the sternum while minimizing concerns associated with tissue compatibility and long-term implant performance. Growing emphasis on reliable postoperative fixation, improved surgical outcomes, and materials capable of withstanding mechanical demands is reinforcing the adoption of titanium in sternal closure procedures.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Procedure | Median Sternotomy, Hemisternotomy, Bilateral Thoracosternotomy, Others | Median Sternotomy | Bilateral Thoracosternotomy |
| Material Type | Stainless Steel, Polyether Ether Ketone (PEEK), Titanium, Others | Titanium | Titanium |
| Type | Closure Devices, Bone Cement | Closure Devices | Closure Devices |
Competitive Landscape and Market Positioning
Major players in the sternal closure systems market:
1. Johnson & Johnson (United States)
2. Zimmer Biomet Holdings Inc. (United States)
3. B. Braun SE (Germany)
4. KLS Martin Group (Germany)
5. Orthofix Medical Inc. (United States)
6. Acumed LLC (United States)
7. Kinamed Incorporated (United States)
8. ABLE Medical Devices (United States)
9. Abyrx Inc. (United States)
10. IDEAR S.r.l. (Italy)
The sternal closure systems market is advancing with improved surgical fixation techniques that enhance post-operative stability. Innovation is focused on reducing recovery time and improving procedural safety. New device designs are incorporating stronger yet flexible materials. The sternal closure systems market is increasingly centered on improving cardiac surgery outcomes.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Johnson & Johnson (United States) | |||||||
| Zimmer Biomet Holdings Inc. (United States) | |||||||
| B. Braun SE (Germany) | |||||||
| KLS Martin Group (Germany) | |||||||
| Orthofix Medical Inc. (United States) | |||||||
| Acumed LLC (United States) | |||||||
| Kinamed Incorporated (United States) | |||||||
| ABLE Medical Devices (United States) | |||||||
| Abyrx Inc. (United States) | |||||||
| IDEAR S.r.l. (Italy). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Exalta | Apr-26 | Montagu Private Equity’s medtech CDMO group rebranded as Exalta, reflecting a strategic repositioning within the contract development and manufacturing sector. The change signals a strengthened operational foundation and a focus on long-term growth in medical technology manufacturing services, including adjacent support for advanced surgical device supply chains. |
| Abyrx | Sep-23 | Abyrx secured expanded FDA approval for its MONTAGE mouldable bone putty, extending its indication to cardiothoracic surgery following sternotomy procedures. The expanded regulatory clearance broadens its use in sternal repair applications, strengthening its role in post-surgical bone stabilization within cardiothoracic closure workflows. |
| Evonik Venture Capital | 2022 | Evonik Venture Capital invested in CircumFix Solutions, a startup developing a sternal closure device utilizing implant-grade polyetheretherketone (PEEK). The investment supports innovation in sternotomy closure technologies aimed at improving post-operative recovery outcomes and enhances material integration in advanced chest fixation systems. |
| Able Medical Devices | Jun-21 | Able Medical Devices launched the Valkyrie Thoracic Fixation System, a single-use radiolucent plating system designed for sternal closure following open-heart surgery. The system introduces a plating-based approach to sternotomy closure, supporting improved stabilization and post-operative recovery in thoracic surgical procedures. |
| Abyrx Inc. | Mar-21 | Abyrx advanced its MONTAGE Bone Putty into Phase 2 clinical trials evaluating its use in conjunction with conventional wire closure versus wire-only sternal repair in post-sternotomy cardiac patients. The study supports clinical validation of biologic augmentation in sternal closure and healing outcomes. |
| Zimmer Biomet | 2020 | Zimmer Biomet acquired A&E Medical for USD 250 million, expanding its thoracic and related surgical product portfolio. The acquisition strengthens its presence across dental, spine, cranial maxillofacial, and thoracic applications, enhancing its capabilities in rigid fixation and sternal closure system technologies. |
| A&E Medical Corporation | Jan-19 | A&E Medical received FDA 510(k) clearance for the Thorecon Rigid Fixation System used for stabilization of anterior chest wall fractures, including post-sternotomy sternal fixation. The clearance enables commercialization of rigid fixation technology for thoracic surgical applications in chest reconstruction and repair. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Sternal Closure Systems Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Surgical Indication | Cardiac Surgery, Thoracic Surgery, Reconstructive Chest Surgery, Trauma Surgery |
| Healthcare Facility Type | Tertiary & Quaternary Hospitals, General Hospitals, Specialty Cardiac Centers, Ambulatory Surgical Centers |
| Purchasing Channel | Direct Hospital Procurement, Group Purchasing Organizations, Distributor-Mediated Procurement, Government & Institutional Procurement |
Sternal Closure Systems Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Cardiac Surgery Procedure Opportunity Assessment |
|
| Hospital Procurement and Adoption Strategy |
|
| Sternal Closure Innovation Roadmap |
|
Need a different cut of the data?
Request Custom ResearchHow much is the sternal closure systems market worth?
What is the anticipated CAGR of the sternal closure systems industry?
How is the rising geriatric population influencing demand dynamics in sternal closure systems for cardiac surgery?
How are increasing cardiothoracic procedure volumes and material innovation reshaping procurement in sternal closure systems?
Why does Median Sternotomy lead the sternal closure systems market?
Why is Bilateral Thoracosternotomy the fastest-growing procedure segment?
Why does North America hold the largest share of the sternal closure systems market?
How is Asia Pacific strengthening its position in the sternal closure systems market?
What are the key competitors in the sternal closure systems landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization